Page 3 - Marketing Approval News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ASKA Pharmaceutical : March 26 2024 ASKA Pharmaceutical Receives Approval for Partial Change of Manufacturing and Marketing Approval for RIFXIMA® TABLETS for Pediatric Indication -March 26, 2024 at 02:18 am EDT

ASKA Pharmaceutical : March 26 2024 ASKA Pharmaceutical Receives Approval for Partial Change of Manufacturing and Marketing Approval for RIFXIMA® TABLETS for Pediatric Indication -March 26, 2024 at 02:18 am EDT
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Minato kuSohta yamaguchiHoldings co ltdCorporate planning departmentJapanese society for pediatric gastroenterologyCo ltdMinistry of healthHa head officeHead officeReceives approvalPartial changeMarketing approvalRepresentative directorJapanese societyPediatric gastroenterologyCorporate planning

Advicenne: FDA Grants Orphan Drug Designation to ADV7103 for the Treatment of Cystinuria

Advicenne: FDA Grants Orphan Drug Designation to ADV7103 for the Treatment of Cystinuria
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesFrance generalAdvicenne euronextStefan klotterDidier laurensDrug administrationRenal tubular acidosisEuronext growth parisOrphan drug designationChief executive officerNorth americaMarketing approvalEuronext parisRegistration documentLassen sie

Advicenne : Inside Information / Other news releases -March 25, 2024 at 04:13 am EDT

FDA grants Orphan Drug Designation to ADV7103 for the treatment of cystinuria. • After distal Renal Tubular Acidosis in December 2022,.

United statesFrance generalAdvicenne euronextDidier laurensDrug administrationOrphan drug designationRenal tubular acidosisEuronext growth parisChief executive officerNorth americaMarketing approvalEuronext parisRegistration document

FDA Grants Orphan Drug Designation to ADV7103 for the Treatment of Cystinuria

FDA Grants Orphan Drug Designation to ADV7103 for the Treatment of Cystinuria
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

France generalUnited statesAdvicenne euronextDidier laurensDrug administrationRenal tubular acidosisEuronext growth parisOrphan drug designationChief executive officerNorth americaMarketing approvalEuronext parisRegistration document

Advicenne Reports 2023 Gross Sales1 up 20% to €4 43 Million

Advicenne Reports 2023 Gross Sales1 up 20% to €4 43 Million
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomFrance generalAdvicenne euronextDidier laurensStefan klotterRegulatory newsEuronext growth parisChief executive officerMiddle eastEastern europeanMarketing approvalEuronext parisRegistration documentDie performance strategieAssets sie